Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Esperion Therapeutics Inc (ESPR)

  7. Esperion Therapeutics Inc (ESPR) Financials

ESPR

Esperion Therapeutics Inc

1.35
-0.01 (-0.74%)
Upgrade to Real-Time

Esperion Therapeutics Inc. (ESPR) Fundamentals
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment.
SHARE INFORMATION
Market Cap$ 128,809,214
Shares Outstanding94,712,657
Float93,700,000
Percent Float98.93%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 24,329,000
Latest Fiscal EPS$ -0.79
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions335
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months14,232,817
Institutional Holdings Percent117.5%
Institutional Sold Previous 3 Months7,676,143
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months185,750
Insider Holdings Percent1.0
Insider Sold Previous 3 Months33,286
Insider Shares Owned756,997
TRADING INFO
52 Week High$ 8.87
52 Week Low$ 1.12
52 Week High Change$ -78.06
21 Day Moving Average$ 1.5126
21 Day Extended Moving Average$ 1.4603
50 Day Moving Average$ 1.4323
50 Day Extended Moving Average$ 1.8753
200 Day Moving Average$ 5.2465
200 Day Extended Moving Average$ 4.4261
10 Day Average Volume1,893,815
20 Day Average Volume2,009,182
30 Day Average Volume1,968,649
50 Day Average Volume2,193,076
Alpha-0.033257
Beta0.1456
Standard Deviation0.182260
R20.001844
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ -0.40
21 Day Percent Change-22.73%
30 Day Price Change$ -0.04
30 Day Percent Change-2.86%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ -0.23
Quarter to Date Percent Change-14.47%
180 Day Price Change$ -4.97
180 Day Percent Change-78.52%
200 Day Price Change$ -5.85
200 Day Percent Change-81.14%
Year to Date Price Change$ -4.87
Year to Date Percent Change-78.17%

Esperion Therapeutics Inc. (ESPR) Key Ratios

PROFITABILITY
EBIT Margin-224.2%
EBITDA Margin-223.4%
Pre-Tax Profit Margin-173.4%
Profit Margin Count-2.54%
Gross Margin80.6%
Profit Margin TOT-2.54%
INCOME STATEMENTS
Revenue$ 24,329,000
Revenue Per Share$ 0.2569
Revenue (3 Years)$ 156.73
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.40
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio3.90
Leverage Ratio0.00
Quick Ratio3.10
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 231,927,087
Price to Sales1.71
Price to Free Cash0.00
PE High Last 5 Years3.30
Price To Book-0.40
Price To Cash Flow-0.80
PE Low Last 5 Years-6.60
Price to Tangible Book-0.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.60
Invoice Turnover0.40
Assets Turnover0.30
Return Assets-80.27
Return on Equity0.00
Return on Capital0.00

Esperion Therapeutics Inc. (ESPR) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEOSheldon L Koenig
Employees218
Last Audit-
CIK0001434868
IndustryPharmaceuticals
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address3891 Ranchero Drive,Suite 150
Suite 150
Ann Arbor, MI 48108
Websitehttps://www.esperion.com
Facsimile-
Telephone+1 734 887-3903
Emailaschwartz@esperion.com


Your Recent History
NASDAQ
ESPR
Esperion T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.